AREV I has invested in NexInLife, aiming to accelerate its growth in the international medical device market, particularly in the catheter industry.

Information on the Target

NexInLife is the parent company of MS Techniques and Transluminal, having recently transitioned under the Saint-Gobain group, while AREV I made an investment alongside the current management team. Established in 1992 and located near Nancy, France, NexInLife caters to an international clientele that includes OEMs, CDMOs, and innovative MedTech firms. MS Techniques specializes in the thermoplastic extrusion of precision components, supplying tubes, sleeves, and sub-components for the medical catheter sector. Meanwhile, Transluminal focuses on the design, prototyping, assembly, and mass production of advanced catheter systems. Both companies operate in clean rooms and adhere to ISO 13485 certification.

Industry Overview in France

The catheter market is experiencing significant growth, driven primarily by the increasing adoption of minimally invasive surgical methods and the aging population across Europe and the United States. This trend presents a substantial opportunity for companies like NexInLife, which specializes in high-value medical applications. France, a key player in the MedTech industry, benefits from a robust healthcare infrastructure and a favorable regulatory environment, bolstering its position in the European healthcare landscape.

The rising demand for advanced medical devices has led to increasing investments in research and development within the sector. French MedTech f